Gå till Affärer
Riskkapital | TMT

IMendes has sold a majority stake to e-Auditoria

The private shareholder of IMendeson has sold a majority stake in the company to e-Auditoria.

IMendes is a leading tax software development company for tax and accounting automation in Brazil. It operates with a SaaS model, providing solutions to more than 30,000 clients across the entire national territory. The company offers tax engine solutions for automation of fiscal processes, reorganization of tax records, and XML validation of invoices with integration to the leading ERPs software in the market. Founded in 2008 by Izac Mendes, the company is headquartered in the city of Ribeirão Preto and has more than 55 employees, including dedicated software developers and tax specialists. IMendes’ solutions integrate with the best and most used ERP platforms in the market while leveraging the sales power of these partnerships to boost market penetration and to generate a profitable business model with recurring revenue. The company is experiencing strong growth in the past few years boosted by its cloud-based solutions and scalability. In addition, the complexity of the fiscal environment in Brazil demands this type of solution to ensure reliable fiscal procedure for businesses.

e-Auditoria is a technology company specializing in digital auditing. Its platform provides security and agility in detecting inconsistencies in accounting, tax and labor obligations, which reduces the risk of fines and audits from the tax authorities, in addition to identifying taxes collected incorrectly by companies, enabling the recovery of settlements. e-Auditoria was founded in 2009 by a group of entrepreneurs and Concept Investimentos, a Brazilian private equity firm, bought a majority stake in 2022.

One of Oaklins’ teams in Brazil acted as the exclusive financial advisor to IMendes and the shareholder in this transaction.

“At all times I was confident that the process was being conducted in a professional and transparent manner so that I could focus on the company and the high growth it is experiencing. Furthermore, Oaklins has a team of professionals who, in addition to being very competent, are tireless; they worked on the preparation process for future due diligence, they organized all the information, reconciling transparency with the truth. At many times I had the feeling that they were protecting my interests and those of IMendes as if they were my partners.”

Izac Mendes

Founder and CEO, IMendes

Prata med transaktionsteamet

Daniel Gildin

Partner
Sao Paulo, Brasilien
Oaklins Fortezza Partners

Priscila Cardanha Rosas

Partner
Sao Paulo, Brasilien
Oaklins Fortezza Partners

Relaterade affärer

Scholarcy Limited has been acquired by Texthelp Group
TMT

Scholarcy Limited has been acquired by Texthelp Group

Texthelp Group, a global provider of digital tools for inclusive learning and working, has acquired Scholarcy Limited. This acquisition marks a significant step towards fulfilling Texthelp’s vision of improving the literacy and understanding of one billion people by 2030.

Lär dig mer
PBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas
Riskkapital | Bygg- & tekniktjänster

PBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas

Nazca Capital and the company founders have sold PBV Investment Holding Europe-America, S.L. (IDP Group) to Bureau Veritas. This strategic acquisition will allow Bureau Veritas to expand its leadership in building and infrastructure solutions and meet sustainability challenges through IDP’s digital portfolio assets.

Lär dig mer
HD Clinical Ltd. has been acquired by NEXUS AG
Hälsovård | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Lär dig mer